Eden Research (LON:EDEN) Issues Quarterly Earnings Results

Eden Research (LON:EDEN) released its earnings results on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Price Performance

Shares of EDEN stock traded down GBX 0.03 on Friday, hitting GBX 2.17. 218,368 shares of the stock traded hands, compared to its average volume of 582,820. The company has a debt-to-equity ratio of 1.43, a current ratio of 2.25 and a quick ratio of 2.42. Eden Research has a 52 week low of GBX 1.96 and a 52 week high of GBX 5. The firm has a 50 day simple moving average of GBX 2.70 and a two-hundred day simple moving average of GBX 3.14. The firm has a market cap of £17.42 million, a price-to-earnings ratio of -4.89 and a beta of 1.57.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.